Published by Persistence MarketResearch
Posted on September 23, 2021
6 min readLast updated: February 2, 2026
The COVID-19 saliva-based screening market is projected to reach $1.7 Bn by 2031, driven by consumer demand and technological advancements in healthcare.
The COVID-19 Saliva-based Screening Market is slated to reach US$ 1.7 Bn at a CAGR of 2.4% between 2026-2031. The present scenario is that of consumers driving as well as the accelerating pace of alteration in the healthcare vertical. This drives the digitally-enabled, seamlessly connected, and on-demand clinician-patient interactions. As such, patient-centric delivery transcending geographical barriers would be the epicenter going forward.
As per Persistence Market Research’s latest industry analysis, the global COVID-19 saliva-based screening market was valued at over US$ 1.7 Bn in 2020, and is expected to exhibit a declining CAGR of -3% over the forecast period of 2021 to 2031.
COVID-19 saliva-based screening is attaining traction in the existing situation, as it is patient-friendly, easy to use, and has a shorter test-to-result timeline. COVID-19 saliva-based screening plays a dynamic role in screening asymptomatic persons, thus sustaining market growth. This is mainly owing to numerous advantages offered by saliva-based tests, growing product approvals by FDA, and a shift toward point-of-care testing.
With the onset of the COVID-19 pandemic, several key players have entered the screening market. Advertising and expansion strategies are also playing an important role in generating market revenue. Furthermore, manufacturers are investing extensively in research & development activities to develop novel techniques that can allow rapid testing and accurate results.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32712
Product launches, approvals, and acquisitions & mergers are rampant in this market space:
Company Profiles:
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/32712
Key Takeaways from Market Study
“Increasing adoption of COVID-19 saliva-based screening, rising ageing population susceptible to COVID-19, and continuous guidance from governments to support the response effect of the pandemic are estimated to boost market growth over the coming years,” says an analyst of Persistence Market Research.
Market Competition
New product approvals, launches, collaborations, agreements, and partnerships have emerged as the main growth strategy implemented by leading players. Acquisitions allow a company to expand its product portfolio. The company that is acquired possesses well-established diagnostic products and solutions, which become a good revenue source for the acquirer. This also enables the company to enter new emerging markets as well as existing markets.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32712
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the COVID-19 saliva-based screening market in its latest study, presenting a historical demand assessment and projections for 2020 – 2031.
The research study is based on the product (saliva collection kits, saliva nucleic acid purification kit and saliva-based detection kits), technology (direct sample to PCR, RT-qPCR and lateral flow assay), application (COVID-19 research and COVID-19 diagnostics), end user (diagnostic laboratories, hospitals & clinics, academic and research institutes, biopharma companies, long term care facilities, home care settings and others), across seven key regions of the world.
Related Reports:
Oral Solid Dosage Contract Manufacturing Market:
The global oral solid dosage contract manufacturing market is estimated to be valued at around US$ 21 Bn in 2020, with the market expected to exhibit a CAGR of close to 6% over the forecast period (2020-2030).
Eye Health Supplements Market:
The global eye health supplements market was valued at US$ 2 Bn in 2019, and is expected to exhibit a CAGR of 6% over the forecast period (2019–2029).
North America Toxicology Laboratories Market:
According to a revised report published by Persistence Market Research, the North America toxicology laboratories market is valued at US$ 180 Mn, and is predicted to surge at a CAGR of 11% over the forecast period (2021–2031).
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
The post The Next 10 Years To See Growth Of COVID-19 Saliva-based Screening Market On Two Fronts – Organic And Inorganic (Reaching US$ 1.7 Bn) appeared first on Lake Shore Gazette.
The article discusses the growth of the COVID-19 saliva-based screening market, projected to reach $1.7 billion by 2031.
Market growth is driven by consumer demand, technological advancements, and increased FDA approvals for saliva-based tests.
Europe is set to dominate the global market with a value share of around 36%.
Explore more articles in the Research Reports category
